恒瑞医药近期的表现令人咋舌,登陆港交所后,一向稳如泰山的作风突然激进起来,两天的涨幅抵得上过去三年的震荡,终于进入了上升通道。事实上,作为“夫妻店”的“一姐”翰森制药,今年以来已取得超90%的涨幅,成绩比“一哥”恒瑞医药要好得多。在过去,这两家“夫妻店”展现出沉稳厚重的形象,但从这两年的发展来看,表现越来越“凶猛”。从某些指标来看,“一姐”的凶猛程度甚至更胜一筹。阿美替尼成功在英国上市,使这样的“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.